CRISPR Therapeutics AG (CRSP)
55.70
-0.06
(-0.11%)
USD |
NASDAQ |
Sep 24, 16:00
55.80
+0.10
(+0.18%)
After-Hours: 07:41
CRISPR Therapeutics Gross Profit (Annual) : -229.45M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -229.45M |
| December 31, 2024 | -92.20M |
| December 31, 2023 | 221.12M |
| December 31, 2022 | -133.22M |
| December 31, 2021 | 897.01M |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.038M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Basilea Pharmaceutica AG | 232.46M |
| Santhera Pharmaceuticals Holding AG | 17.42M |
| BeOne Medicines Ltd. | 4.569B |
| AC Immune SA | 0.00 |